KR100798600B1 - 마크로시클릭 유사체 및 그들의 이용 및 제조방법 - Google Patents
마크로시클릭 유사체 및 그들의 이용 및 제조방법 Download PDFInfo
- Publication number
- KR100798600B1 KR100798600B1 KR1020007014229A KR20007014229A KR100798600B1 KR 100798600 B1 KR100798600 B1 KR 100798600B1 KR 1020007014229 A KR1020007014229 A KR 1020007014229A KR 20007014229 A KR20007014229 A KR 20007014229A KR 100798600 B1 KR100798600 B1 KR 100798600B1
- Authority
- KR
- South Korea
- Prior art keywords
- mmol
- etoac
- added
- mixture
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 0 COC(CC(CC1)O[C@]2[C@]1O[C@]([C@@](*)C=CI)C(*)[C@]2*)=O Chemical compound COC(CC(CC1)O[C@]2[C@]1O[C@]([C@@](*)C=CI)C(*)[C@]2*)=O 0.000 description 34
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8968298P | 1998-06-17 | 1998-06-17 | |
| US60/089,682 | 1998-06-17 | ||
| PCT/US1999/013677 WO1999065894A1 (en) | 1998-06-17 | 1999-06-16 | Macrocyclic analogs and methods of their use and preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20010083050A KR20010083050A (ko) | 2001-08-31 |
| KR100798600B1 true KR100798600B1 (ko) | 2008-01-28 |
Family
ID=22219026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020007014229A Expired - Lifetime KR100798600B1 (ko) | 1998-06-17 | 1999-06-16 | 마크로시클릭 유사체 및 그들의 이용 및 제조방법 |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US6214865B1 (https=) |
| EP (4) | EP2277873B1 (https=) |
| JP (1) | JP4454151B2 (https=) |
| KR (1) | KR100798600B1 (https=) |
| CN (1) | CN1216051C (https=) |
| AT (1) | ATE502932T1 (https=) |
| AU (1) | AU762998B2 (https=) |
| BE (1) | BE2011C028I2 (https=) |
| BR (1) | BRPI9911326B8 (https=) |
| CA (3) | CA2755266C (https=) |
| CY (2) | CY1111516T1 (https=) |
| DE (2) | DE122011100031I1 (https=) |
| DK (1) | DK1087960T3 (https=) |
| FR (1) | FR11C0038I2 (https=) |
| HU (1) | HU227912B1 (https=) |
| IL (1) | IL139960A0 (https=) |
| LU (1) | LU91854I2 (https=) |
| NO (5) | NO328280B1 (https=) |
| NZ (1) | NZ508597A (https=) |
| PT (1) | PT1087960E (https=) |
| WO (1) | WO1999065894A1 (https=) |
| ZA (1) | ZA200007159B (https=) |
Families Citing this family (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8097648B2 (en) * | 1998-06-17 | 2012-01-17 | Eisai R&D Management Co., Ltd. | Methods and compositions for use in treating cancer |
| US6653341B1 (en) | 1998-06-17 | 2003-11-25 | Eisai Co., Ltd. | Methods and compositions for use in treating cancer |
| US6214865B1 (en) * | 1998-06-17 | 2001-04-10 | Eisai Co., Ltd. | Macrocyclic analogs and methods of their use and preparation |
| DE10037310A1 (de) | 2000-07-28 | 2002-02-07 | Asta Medica Ag | Neue Indolderivate und deren Verwendung als Arzneimittel |
| EP1531846A4 (en) * | 2002-02-27 | 2006-04-19 | Us Gov Health & Human Serv | Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use |
| AU2003228354B8 (en) | 2002-03-22 | 2010-03-04 | Eisai R&D Management Co., Ltd. | Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| US20050075395A1 (en) * | 2003-05-28 | 2005-04-07 | Gary Gordon | Continuous dosing regimen |
| EP1644008B1 (en) * | 2003-05-29 | 2011-12-21 | Abbott Laboratories | Continuous dosing regimen with abt-751 |
| EP1653953A4 (en) * | 2003-07-29 | 2010-05-05 | Eisai R&D Man Co Ltd | METHOD AND DEVICES FOR THE MEDICINAL PRODUCTION |
| EP2522663B1 (en) | 2004-06-03 | 2015-04-01 | Eisai R&D Management Co., Ltd. | Intermediates for the preparation of halichondrin B |
| CA2822994C (en) * | 2004-06-03 | 2016-09-27 | Eisai R&D Management Co., Ltd. | Intermediates for the preparation of analogs of halichondrin b |
| US20060045846A1 (en) * | 2004-08-30 | 2006-03-02 | Horstmann Thomas E | Reagents and methods for labeling terminal olefins |
| EP1831697A4 (en) * | 2004-12-09 | 2011-01-26 | Eisai R&D Man Co Ltd | SEARCH FOR TUBULINISOTYPES IN CANCER THERAPY USING HALICHONDRIN B ANALOG |
| RU2489437C2 (ru) * | 2007-10-03 | 2013-08-10 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Промежуточные соединения и способы синтеза аналогов галихондрина в |
| CN105801599A (zh) * | 2008-04-04 | 2016-07-27 | 卫材R&D管理有限公司 | 软海绵素b类似物 |
| EP2415464B1 (en) | 2009-03-30 | 2017-05-10 | Eisai R&D Management Co., Ltd. | Method for producing liposome composition |
| RU2476216C1 (ru) * | 2009-03-30 | 2013-02-27 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Липосомальная композиция |
| ES2593027T3 (es) | 2009-03-30 | 2016-12-05 | Eisai R&D Management Co., Ltd. | Composición liposomal |
| EP2420504B1 (en) * | 2009-04-14 | 2014-01-15 | Nissan Chemical Industries, Ltd. | Method for producing tetrahydropyran compound and intermediate thereof |
| DK2468281T3 (en) | 2009-08-19 | 2016-03-21 | Eisai R&D Man Co Ltd | Quinolinderivatholdig pharmaceutical composition |
| WO2011094339A1 (en) | 2010-01-26 | 2011-08-04 | Eisai R&D Management Co., Ltd. | Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs |
| EP2686441B1 (en) | 2011-03-18 | 2019-05-08 | Eisai R&D Management Co., Ltd. | Methods and uses for predicting response to eribulin |
| WO2012147900A1 (en) | 2011-04-28 | 2012-11-01 | Eisai R&D Management Co., Ltd. | Microreactor process for halichondrin b analog synthesis |
| JP6038128B2 (ja) | 2011-06-03 | 2016-12-07 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | レンバチニブ化合物に対する甲状腺癌対象及び腎臓癌対象の反応性を予測及び評価するためのバイオマーカー |
| EP2785687B1 (en) | 2011-11-30 | 2019-02-20 | Sandoz AG | Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene |
| CN104024237B (zh) | 2011-12-16 | 2016-02-24 | 阿方拉研究股份有限公司 | 用于制备3-((2s,5s)-4-亚甲基-5-(3-氧代丙基)四氢呋喃-2-基)丙醇衍生物的方法及其有用的中间体 |
| CN104080793B (zh) * | 2011-12-29 | 2017-09-19 | 阿方拉研究股份有限公司 | 2‑((2s,3s,4r,5r)‑5‑((s)‑3‑氨基‑2‑羟基丙‑1‑基)‑4‑甲氧基‑3‑(苯磺酰甲基)四氢呋喃‑2‑基)乙醛衍生物以及它们的制备方法 |
| WO2013142999A1 (en) * | 2012-03-30 | 2013-10-03 | Alphora Research Inc. | Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein |
| MX2015007185A (es) | 2012-12-04 | 2017-09-05 | Eisai R&D Man Co Ltd | Uso de eribulina en el tratamiento de cancer de pecho. |
| AR096238A1 (es) | 2013-05-15 | 2015-12-16 | Alphora Res Inc | Proceso para preparar derivados de 3-((2s,5s)-4-metilen-5-(3-oxopropil)tetrahidrofuran-2-il)propanol e intermediarios útiles para el mismo |
| KR102265952B1 (ko) | 2013-06-26 | 2021-06-16 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 암 치료 병용요법으로서 에리불린 및 렌바티닙의 용도 |
| CA2916537C (en) * | 2013-07-03 | 2021-07-27 | Alphora Research Inc. | Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups |
| CN103483352A (zh) * | 2013-10-18 | 2014-01-01 | 李友香 | 抗肿瘤的药用原料药 |
| EP3689881B1 (en) | 2013-11-04 | 2022-01-12 | Eisai R&D Management Co., Ltd. | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b |
| MX384292B (es) * | 2013-12-06 | 2025-03-14 | Eisai R&D Man Co Ltd | Metodos utiles en la sintesis de analogos de halicondrina b. |
| CN104860978A (zh) * | 2014-02-20 | 2015-08-26 | 正大天晴药业集团股份有限公司 | 软海绵素b类似物的合成中间体 |
| TW201617326A (zh) * | 2014-03-06 | 2016-05-16 | Ａｌｐｈｏｒａ研發股份有限公司 | （ｓ）－１－（（２ｒ，３ｒ，４ｓ，５ｓ）－５－烯丙－３－甲氧－４－（對甲苯磺醯甲基）四氫呋喃－２－基）－３－氨基丙－２－醇之結晶衍生物 |
| RU2699545C2 (ru) * | 2014-05-28 | 2019-09-06 | ЭЙСАЙ Ар ЭНД Ди МЕНЕДЖМЕНТ КО., ЛТД | Применение эрибулина в лечении рака |
| US10556910B2 (en) * | 2014-06-30 | 2020-02-11 | President And Fellows Of Harvard College | Synthesis of halichondrin analogs and uses thereof |
| PT3524595T (pt) | 2014-08-28 | 2022-09-19 | Eisai R&D Man Co Ltd | Derivado de quinolina altamente puro e método para produção do mesmo |
| WO2016038624A1 (en) | 2014-09-09 | 2016-03-17 | Cipla Limited | "process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof" |
| CN105713031B (zh) * | 2014-12-05 | 2021-05-07 | 正大天晴药业集团股份有限公司 | 一种用于制备艾日布林的中间体及其制备方法 |
| AU2016224583B2 (en) | 2015-02-25 | 2021-06-03 | Eisai R&D Management Co., Ltd. | Method for suppressing bitterness of quinoline derivative |
| CA2978311A1 (en) | 2015-03-04 | 2016-09-09 | Merck Sharp & Dohme Corp. | Combination of a pd-1 antagonist and eribulin for treating cancer |
| KR102662228B1 (ko) | 2015-03-04 | 2024-05-02 | 머크 샤프 앤드 돔 코포레이션 | 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합 |
| US10344038B2 (en) | 2015-04-30 | 2019-07-09 | President And Fellows Of Harvard College | Chromium-mediated coupling and application to the synthesis of halichondrins |
| KR102743950B1 (ko) | 2015-05-07 | 2024-12-18 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 할리콘드린 마크롤라이드의 합성에 유용한 마크로고리화 반응 및 중간체 및 기타 단편 |
| WO2016182850A1 (en) | 2015-05-08 | 2016-11-17 | Albany Molecular Research, Inc. | Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof |
| BR112017027227B1 (pt) | 2015-06-16 | 2023-12-12 | Eisai R&D Management Co., Ltd | Agente anti-câncer |
| JP6553726B2 (ja) | 2015-08-20 | 2019-07-31 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 腫瘍治療剤 |
| EP3413887B1 (en) * | 2016-02-12 | 2021-04-07 | Eisai R&D Management Co., Ltd. | Intermediates in the synthesis of eribulin and related methods of synthesis |
| US12029724B2 (en) | 2016-04-28 | 2024-07-09 | Eisai R&D Management Co., Ltd. | Method for inhibiting tumor growth |
| KR20190009326A (ko) * | 2016-05-26 | 2019-01-28 | 닥터 레디스 레보러터리즈 리미티드 | 에리불린 및 그의 중간체의 제조방법 |
| US11136335B2 (en) | 2016-06-30 | 2021-10-05 | Eisai R&D Management Co., Ltd. | Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof |
| BR112019007145A2 (pt) | 2016-10-14 | 2019-07-02 | Eisai R&D Man Co Ltd | combinação de um antagonista de pd-1 e eribulina para o tratamento de câncer urotelial |
| JP6978758B2 (ja) | 2016-11-11 | 2021-12-08 | プレジデント アンド フェローズ オブ ハーバード カレッジ | パラジウム媒介ケトール化 |
| CN110167536A (zh) * | 2016-11-23 | 2019-08-23 | 雷迪博士实验室有限公司 | 艾日布林及其中间体的制备方法 |
| KR101880939B1 (ko) | 2017-01-02 | 2018-08-17 | 연성정밀화학(주) | 에리불린 메실산염의 제조 중간체 및 그의 제조방법 |
| KR101991710B1 (ko) | 2017-12-14 | 2019-06-21 | 연성정밀화학(주) | 에리불린 메실산염의 제조 중간체 및 그의 제조방법 |
| JP6920699B2 (ja) * | 2017-01-02 | 2021-08-18 | ヨンスン ファイン ケミカル カンパニー，リミテッド | エリブリンメシル酸塩の製造中間体及びその製造方法 |
| CN108341828B (zh) * | 2017-01-24 | 2021-04-06 | 江苏恒瑞医药股份有限公司 | 用于制备艾日布林的方法及其中间体 |
| CN108341738B (zh) * | 2017-01-24 | 2022-10-21 | 江苏恒瑞医药股份有限公司 | 用于制备艾日布林的方法及其中间体 |
| JP6581320B2 (ja) | 2017-02-08 | 2019-09-25 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 腫瘍治療用医薬組成物 |
| US9938288B1 (en) | 2017-04-05 | 2018-04-10 | President And Fellows Of Harvard College | Macrocyclic compound and uses thereof |
| ES2931533T3 (es) | 2017-04-05 | 2022-12-30 | Harvard College | Compuesto macrocíclico y usos del mismo |
| EP3624800A4 (en) | 2017-05-16 | 2021-02-17 | Eisai R&D Management Co., Ltd. | TREATMENT OF HEPATOCELLULAR CARCINOMA |
| HUE061306T2 (hu) | 2017-07-06 | 2023-06-28 | Harvard College | Halikondrinok szintézise |
| US11498892B2 (en) | 2017-07-06 | 2022-11-15 | President And Fellows Of Harvard College | Fe/Cu-mediated ketone synthesis |
| US20190046513A1 (en) | 2017-08-10 | 2019-02-14 | Huya Bioscience International, Llc | Combination therapies of hdac inhibitors and tubulin inhibitors |
| CN109694379B (zh) * | 2017-10-24 | 2020-09-11 | 江苏恒瑞医药股份有限公司 | 用于制备艾日布林的中间体及其制备方法 |
| JP6967811B2 (ja) * | 2017-11-09 | 2021-11-17 | ヨンスン ファイン ケミカル カンパニー，リミテッド | エリブリンメシル酸塩の製造中間体及びその製造方法 |
| CN111566113B (zh) | 2017-11-15 | 2024-01-09 | 哈佛大学的校长及成员们 | 大环化合物及其用途 |
| US11419856B2 (en) | 2017-11-20 | 2022-08-23 | Basilea Pharmaceutica International AG | Pharmaceutical combinations for use in the treatment of neoplastic diseases |
| US11008296B2 (en) | 2017-11-21 | 2021-05-18 | Natco Pharma Limited | Intermediates for the preparation of eribulin thereof |
| SG11202005548WA (en) | 2018-01-03 | 2020-07-29 | Eisai R&D Man Co Ltd | Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof |
| WO2019211877A1 (en) | 2018-05-03 | 2019-11-07 | Cipla Limited | Process for the preparation of macrocyclic ketone analogs of halichondrin b |
| WO2020008382A1 (en) * | 2018-07-04 | 2020-01-09 | Dr. Reddy’S Laboratories Limited | Process for preparation of eribulin and intermediates thereof |
| JP2021532102A (ja) * | 2018-07-20 | 2021-11-25 | ドクター レディズ ラボラトリーズ リミテッド | エリブリンおよびその中間体の調製のための精製プロセス |
| EP3864011A4 (en) * | 2018-10-09 | 2022-06-29 | Dr. Reddy's Laboratories Ltd. | Process for preparation of eribulin and intermediates thereof |
| US12522611B2 (en) * | 2018-11-28 | 2026-01-13 | Natco Pharma Limited | Process for the preparation of high pure Eribulin and its Mesylate salt |
| MX2021007562A (es) | 2018-12-20 | 2021-09-28 | Auransa Inc | Analogos de pentamidina y usos para estos. |
| US11447499B2 (en) | 2019-06-14 | 2022-09-20 | Rk Pharma Inc. | Process for the preparation of eribulin mesylate intermediate |
| JP7574232B2 (ja) | 2019-06-21 | 2024-10-28 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ | ホモプロパルギルアルコールを調製するための化学酵素的プロセス |
| US11083705B2 (en) | 2019-07-26 | 2021-08-10 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition for treating tumor |
| US12036204B2 (en) | 2019-07-26 | 2024-07-16 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition for treating tumor |
| JP7657213B2 (ja) | 2019-11-07 | 2025-04-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗メソテリンエリブリン抗体－薬物コンジュゲート及び使用方法 |
| CN113135876B (zh) * | 2020-01-16 | 2024-05-17 | 南通诺泰生物医药技术有限公司 | 艾日布林及其中间体的制备方法 |
| CN118949063A (zh) * | 2020-01-22 | 2024-11-15 | 上海森辉医药有限公司 | 艾日布林衍生物的药物偶联物、其制备方法及其在医药上的应用 |
| KR102377262B1 (ko) | 2020-05-11 | 2022-03-22 | 연성정밀화학(주) | 결정성 에리불린 염 |
| IL279168B (en) * | 2020-12-02 | 2022-04-01 | Finetech Pharmaceutical Ltd | A process for the preparation of eribulin |
| CN113354659B (zh) | 2021-06-08 | 2022-04-08 | 江苏慧聚药业股份有限公司 | 甲磺酸艾日布林的合成 |
| AU2022316425A1 (en) * | 2021-07-22 | 2024-02-01 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Drug conjugate of eribulin derivative |
| WO2023212746A2 (en) * | 2022-04-30 | 2023-11-02 | William Marsh Rice University | A unified strategy for the total syntheses of eribulin and a macrolactam analogue of halichondrin b |
| KR20250133788A (ko) * | 2023-01-17 | 2025-09-08 | 시스트이뮨, 인코포레이티드 | 에리불린 약물 접합체 |
| EP4725969A1 (en) | 2023-06-09 | 2026-04-15 | Latticon (Suzhou) Biopharmaceuticals Co., Ltd. | Anti-her2 complementary bispecific antibody-drug conjugate, preparation method therefor and use thereof |
| CN118834221B (zh) * | 2023-08-08 | 2025-10-21 | 浙江星月药物科技有限公司 | 一种软海绵素b类似物 |
| TW202518024A (zh) | 2023-10-13 | 2025-05-01 | 日商衛材R&D企管股份有限公司 | 抗體－藥物軛合物代謝物 |
| WO2025106586A1 (en) * | 2023-11-13 | 2025-05-22 | Luxvitae Therapeutics Inc. | Macrocyclic ketone compounds and applications thereof |
| WO2025228172A1 (zh) * | 2024-04-28 | 2025-11-06 | 上海拓济医药有限责任公司 | 艾日布林衍生物及其抗体药物偶联物和医药用途 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993017690A1 (en) * | 1992-03-12 | 1993-09-16 | President And Fellows Of Harvard College | Halichondrins and related compounds |
| EP0572109A1 (en) * | 1992-03-23 | 1993-12-01 | Pharma Mar, S.A. | Halichondrins: Cytotoxic polyether macrolides |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5436238A (en) | 1992-03-12 | 1995-07-25 | President And Fellows Of Harvard College | Halichondrins and related compounds |
| US5426194A (en) * | 1993-01-19 | 1995-06-20 | Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University | Isolation and structure of Halistatin 1 |
| US6214865B1 (en) | 1998-06-17 | 2001-04-10 | Eisai Co., Ltd. | Macrocyclic analogs and methods of their use and preparation |
| US6653341B1 (en) * | 1998-06-17 | 2003-11-25 | Eisai Co., Ltd. | Methods and compositions for use in treating cancer |
| EP2522663B1 (en) | 2004-06-03 | 2015-04-01 | Eisai R&D Management Co., Ltd. | Intermediates for the preparation of halichondrin B |
| RU2489437C2 (ru) | 2007-10-03 | 2013-08-10 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Промежуточные соединения и способы синтеза аналогов галихондрина в |
| RU2010118063A (ru) * | 2007-11-16 | 2011-12-27 | ЭЙСАЙ Ар энд Ди МЕНЕДЖМЕНТ КО., ЛТД. (JP) | Новое промежуточное соединение для синтеза аналога галихондрина в и новая реакция десульфонилирования, применяемая для получения промежуточного соединения |
| CN105801599A (zh) * | 2008-04-04 | 2016-07-27 | 卫材R&D管理有限公司 | 软海绵素b类似物 |
| WO2011094339A1 (en) | 2010-01-26 | 2011-08-04 | Eisai R&D Management Co., Ltd. | Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs |
-
1999
- 1999-06-16 US US09/334,488 patent/US6214865B1/en not_active Expired - Lifetime
- 1999-06-16 HU HU0103357A patent/HU227912B1/hu active Protection Beyond IP Right Term
- 1999-06-16 CA CA2755266A patent/CA2755266C/en not_active Expired - Lifetime
- 1999-06-16 CA CA002335300A patent/CA2335300C/en not_active Expired - Lifetime
- 1999-06-16 NZ NZ508597A patent/NZ508597A/en not_active IP Right Cessation
- 1999-06-16 CA CA2632433A patent/CA2632433C/en not_active Expired - Lifetime
- 1999-06-16 DE DE201112100031 patent/DE122011100031I1/de active Pending
- 1999-06-16 EP EP10010772A patent/EP2277873B1/en not_active Expired - Lifetime
- 1999-06-16 AU AU45739/99A patent/AU762998B2/en not_active Expired
- 1999-06-16 DE DE69943296T patent/DE69943296D1/de not_active Expired - Lifetime
- 1999-06-16 CN CN99809658XA patent/CN1216051C/zh not_active Expired - Lifetime
- 1999-06-16 PT PT99928746T patent/PT1087960E/pt unknown
- 1999-06-16 IL IL13996099A patent/IL139960A0/xx active Protection Beyond IP Right Term
- 1999-06-16 WO PCT/US1999/013677 patent/WO1999065894A1/en not_active Ceased
- 1999-06-16 KR KR1020007014229A patent/KR100798600B1/ko not_active Expired - Lifetime
- 1999-06-16 DK DK99928746.9T patent/DK1087960T3/da active
- 1999-06-16 AT AT99928746T patent/ATE502932T1/de active
- 1999-06-16 JP JP2000554719A patent/JP4454151B2/ja not_active Expired - Lifetime
- 1999-06-16 EP EP10010774A patent/EP2272840B1/en not_active Expired - Lifetime
- 1999-06-16 BR BRPI9911326A patent/BRPI9911326B8/pt not_active IP Right Cessation
- 1999-06-16 EP EP10010773A patent/EP2272839B1/en not_active Expired - Lifetime
- 1999-06-16 EP EP99928746A patent/EP1087960B1/en not_active Expired - Lifetime
-
2000
- 2000-10-02 US US09/677,485 patent/US6365759B1/en not_active Expired - Lifetime
- 2000-12-04 ZA ZA200007159A patent/ZA200007159B/en unknown
- 2000-12-12 NO NO20006316A patent/NO328280B1/no not_active IP Right Cessation
-
2001
- 2001-04-26 US US09/843,617 patent/US6469182B1/en not_active Expired - Lifetime
-
2009
- 2009-10-26 NO NO20093217A patent/NO331183B1/no active Protection Beyond IP Right Term
-
2010
- 2010-08-12 US US12/855,412 patent/US8148554B2/en not_active Expired - Fee Related
-
2011
- 2011-06-01 CY CY20111100530T patent/CY1111516T1/el unknown
- 2011-08-12 CY CY2011010C patent/CY2011010I2/el unknown
- 2011-08-17 LU LU91854C patent/LU91854I2/fr unknown
- 2011-09-02 BE BE2011C028C patent/BE2011C028I2/fr unknown
- 2011-09-09 FR FR11C0038C patent/FR11C0038I2/fr active Active
- 2011-09-16 NO NO2011018C patent/NO2011018I1/no unknown
- 2011-12-14 NO NO2011026C patent/NO2011026I2/no unknown
-
2022
- 2022-06-03 NO NO2022019C patent/NO2022019I1/no unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993017690A1 (en) * | 1992-03-12 | 1993-09-16 | President And Fellows Of Harvard College | Halichondrins and related compounds |
| EP0572109A1 (en) * | 1992-03-23 | 1993-12-01 | Pharma Mar, S.A. | Halichondrins: Cytotoxic polyether macrolides |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100798600B1 (ko) | 마크로시클릭 유사체 및 그들의 이용 및 제조방법 | |
| AU2003224672B2 (en) | Macrocyclic compounds useful as pharmaceuticals | |
| KR102001910B1 (ko) | 항암제의 나이트로벤질 유도체 | |
| US6624189B2 (en) | Byrostatin analogues, synthetic methods and uses | |
| EP2334686B1 (en) | Cortistatin analogues and syntheses therof | |
| JPH09500128A (ja) | イミダゾ〔４，５−ｃ〕ピリジン−４−アミン | |
| PL189311B1 (pl) | Nowe taksoidy, sposób ich wytwarzania i kompozycje farmaceutyczne zawierające te związki | |
| Manfredini et al. | Geiparvarin Analogs. 4.1. Synthesis and Cytostatic Activity of Geiparvarin Analogs Bearing a Carbamate Moiety or a Furocoumarin Fragment on the Alkenyl Side Chain | |
| EP1101765B1 (fr) | Nouveaux composés analogues de la camptothécine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
| ES2364696T3 (es) | Análogos macrocíclicos y procedimientos para su uso y preparación. | |
| RU2822750C2 (ru) | Микроциклические аналоги и способы их применения и получения | |
| HK1035534B (en) | Macrocyclic analogs and methods of their use and preparation | |
| JPH09507864A (ja) | タキサン誘導体 | |
| EP1758904B1 (en) | Flavopereirine derivatives for cancer therapy | |
| MXPA00012534A (en) | Macrocyclic analogs and methods of their use and preparation | |
| KR20050053599A (ko) | 미리아포론의 전합성 | |
| JPH11504029A (ja) | 新規な置換テトラヒドロピラノ［３，２−ｄ］オキサゾロン類、それらを製造する方法及びそれらを含む製薬学的組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20001215 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20040614 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20060127 Patent event code: PE09021S01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20070821 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20071227 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20080121 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20080121 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20110112 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20120109 Start annual number: 5 End annual number: 5 |
|
| J202 | Request for trial for correction [limitation] | ||
| PJ0202 | Trial for correction |
Comment text: Request for Trial Patent event date: 20120531 Patent event code: PJ02022R01D Comment text: Registration of Establishment Patent event date: 20080121 Patent event code: PJ02021E01I Appeal kind category: Correction Decision date: 20121102 Request date: 20120531 Appeal identifier: 2012105000054 |
|
| PG1701 | Publication of correction |
Publication date: 20120831 |
|
| A101 | Application to extend term of patent right by permit | ||
| PA0101 | Application to register extension of term of patent right by permit, etc. |
Patent event date: 20121029 Patent event code: PA01011R01D Comment text: Application to Register Extension of Term of Patent Right by Permit, etc. |
|
| J301 | Trial decision |
Free format text: TRIAL DECISION FOR CORRECTION REQUESTED 20120531 Effective date: 20121102 Free format text: TRIAL NUMBER: 2012105000054; TRIAL DECISION FOR CORRECTION REQUESTED 20120531 Effective date: 20121102 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S03D Patent event date: 20121102 Comment text: Trial Decision on Correction (Patent, Utility Model) Appeal kind category: Correction Request date: 20120531 Decision date: 20121102 Appeal identifier: 2012105000054 |
|
| FPAY | Annual fee payment |
Payment date: 20130109 Year of fee payment: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20130109 Start annual number: 6 End annual number: 6 |
|
| J251 | Registration of extension of term of patent right | ||
| FPAY | Annual fee payment |
Payment date: 20140107 Year of fee payment: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20140107 Start annual number: 7 End annual number: 7 |
|
| FPAY | Annual fee payment |
Payment date: 20150107 Year of fee payment: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20150107 Start annual number: 8 End annual number: 8 |
|
| J204 | Request for invalidation trial [patent] | ||
| J252 | Request for trial |
Free format text: TRIAL NUMBER: 2015100001293; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100001294; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100001295; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100001296; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100001297; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100001298; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100001299; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM |
|
| PJ0205 | Invalidation trial for registration of extension of term of patent right |
Decision date: 20160415 Appeal identifier: 2015100001299 Appeal kind category: Invalidation of Extension of Term Request date: 20150320 Appeal identifier: 2015100001298 Appeal kind category: Invalidation of Extension of Term Request date: 20150320 Decision date: 20160415 Appeal identifier: 2015100001297 Appeal kind category: Invalidation of Extension of Term Request date: 20150320 Appeal identifier: 2015100001296 Appeal kind category: Invalidation of Extension of Term Request date: 20150320 Decision date: 20160415 Appeal identifier: 2015100001295 Appeal kind category: Invalidation of Extension of Term Request date: 20150320 Decision date: 20160415 Appeal identifier: 2015100001294 Appeal kind category: Invalidation of Extension of Term Request date: 20150320 Comment text: Request for Trial Patent event code: PJ02052R01D Patent event date: 20150320 Comment text: Registration of Extension of Term of Patent Right Patent event code: PJ02051S01I Patent event date: 20130128 Decision date: 20160415 Appeal identifier: 2015100001293 Appeal kind category: Invalidation of Extension of Term Request date: 20150320 |
|
| J204 | Request for invalidation trial [patent] | ||
| J252 | Request for trial |
Free format text: TRIAL NUMBER: 2015100001979; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100001981; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100001982; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100001983; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100001990; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100001993; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100002000; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100002003; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM Free format text: TRIAL NUMBER: 2015100002125; INVALIDATION TRIAL FOR REGISTRATION OF EXTENSION OF TERM OF PATENT RIGHT FOR INVALIDATION OF EXTENSION OF TERM |
|
| PJ0205 | Invalidation trial for registration of extension of term of patent right |
Decision date: 20160429 Appeal identifier: 2015100002125 Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Decision date: 20150513 Appeal identifier: 2015100002003 Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Appeal identifier: 2015100002000 Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Appeal identifier: 2015100001993 Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Appeal identifier: 2015100001990 Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Decision date: 20150608 Appeal identifier: 2015100001983 Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Decision date: 20160415 Appeal identifier: 2015100001982 Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Decision date: 20150506 Appeal identifier: 2015100001981 Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Comment text: Request for Trial Patent event code: PJ02052R01D Patent event date: 20150403 Comment text: Registration of Extension of Term of Patent Right Patent event code: PJ02051S01I Patent event date: 20130128 Appeal identifier: 2015100001979 Appeal kind category: Invalidation of Extension of Term Request date: 20150403 |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20150506 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2015100001981 Request date: 20150403 Appeal kind category: Invalidation of Extension of Term Decision date: 20150506 |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20150513 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2015100002003 Request date: 20150403 Appeal kind category: Invalidation of Extension of Term Decision date: 20150513 |
|
| J501 | Disposition of invalidation of trial | ||
| PJ0501 | Disposition of invalidation of trial |
Comment text: Request for Amendment Patent event date: 20010329 Patent event code: PJ05011S01I Appeal kind category: Invalidation of Extension of Term Request date: 20150320 Appeal identifier: 2015100001296 |
|
| J501 | Disposition of invalidation of trial | ||
| PJ0501 | Disposition of invalidation of trial |
Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Appeal identifier: 2015100001993 Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Appeal identifier: 2015100001990 Comment text: Request for Amendment Patent event date: 20010329 Patent event code: PJ05011S01I Appeal kind category: Invalidation of Extension of Term Request date: 20150320 Appeal identifier: 2015100001298 |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20150608 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2015100001983 Request date: 20150403 Appeal kind category: Invalidation of Extension of Term Decision date: 20150608 |
|
| J501 | Disposition of invalidation of trial | ||
| PJ0501 | Disposition of invalidation of trial |
Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Appeal identifier: 2015100002000 Comment text: Request for Amendment Patent event date: 20010329 Patent event code: PJ05011S01I Appeal kind category: Invalidation of Extension of Term Request date: 20150403 Appeal identifier: 2015100001979 |
|
| FPAY | Annual fee payment |
Payment date: 20160111 Year of fee payment: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 20160111 Start annual number: 9 End annual number: 9 |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Appeal identifier: 2015100001982 Request date: 20150403 Appeal kind category: Invalidation of Extension of Term Decision date: 20160415 Appeal identifier: 2015100001299 Request date: 20150320 Appeal kind category: Invalidation of Extension of Term Decision date: 20160415 Appeal identifier: 2015100001297 Request date: 20150320 Appeal kind category: Invalidation of Extension of Term Decision date: 20160415 Appeal identifier: 2015100001295 Request date: 20150320 Appeal kind category: Invalidation of Extension of Term Decision date: 20160415 Appeal identifier: 2015100001294 Request date: 20150320 Appeal kind category: Invalidation of Extension of Term Decision date: 20160415 Patent event code: PJ12011R01D Patent event date: 20160415 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2015100001293 Request date: 20150320 Appeal kind category: Invalidation of Extension of Term Decision date: 20160415 |
|
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20160429 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2015100002125 Request date: 20150403 Appeal kind category: Invalidation of Extension of Term Decision date: 20160429 |
|
| FPAY | Annual fee payment |
Payment date: 20170113 Year of fee payment: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20170113 Start annual number: 10 End annual number: 10 |
|
| FPAY | Annual fee payment |
Payment date: 20180108 Year of fee payment: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 20180108 Start annual number: 11 End annual number: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20190109 Year of fee payment: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20190109 Start annual number: 12 End annual number: 12 |
|
| FPAY | Annual fee payment |
Payment date: 20200109 Year of fee payment: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 20200109 Start annual number: 13 End annual number: 13 |
|
| PC1801 | Expiration of term |